Julia Carbonetti

Counsel

Overview

Julia Carbonetti is a counsel in the firm’s Washington, D.C. office, where she practices in the Mass Torts, Product, and Consumer Litigation Group.

Julia represents clients in complex tort and product liability matters, with a particular focus on the transportation industry. She handles all aspects of litigation, including dispositive motions, mediations, and/or arbitrations. She also has experience defending clients in breach of warranty and negligence cases.

Julia served as a law clerk to the Honorable Joseph M. Getty, Court of Appeals of Maryland, and as a judicial law clerk to the Honorable Fred S. Hecker, Circuit Court for Carroll County, Maryland. She was the Notes & Comments Editor of the Journal of Business and Technology while in law school.

Career & Education

|
    • University of Maryland, College Park, B.A., 2013
    • University of Maryland School of Law, J.D., cum laude, 2016
    • University of Maryland, College Park, B.A., 2013
    • University of Maryland School of Law, J.D., cum laude, 2016
    • Maryland
    • District of Columbia
    • U.S. District Court for the District of Maryland
    • U.S. District Court for the District of Columbia
    • Maryland
    • District of Columbia
    • U.S. District Court for the District of Maryland
    • U.S. District Court for the District of Columbia

Julia's Insights

Client Alert | 2 min read | 06.26.24

FDA Unveils Its “First Look” Into How It Will Enforce MoCRA

A warning letter posted by the Food and Drug Administration (FDA) on June 18, 2024 offers a first glimpse into how FDA may enforce its new regulatory scheme for products that fall within the Modernization of Cosmetics Regulation Act of 2022 (MoCRA)’s purview. While MoCRA was enacted in December 2022 and many of its provisions became enforceable on December 29, 2023, until now, many have wondered how FDA will exercise its new enforcement powers....

|

Julia's Insights

Client Alert | 2 min read | 06.26.24

FDA Unveils Its “First Look” Into How It Will Enforce MoCRA

A warning letter posted by the Food and Drug Administration (FDA) on June 18, 2024 offers a first glimpse into how FDA may enforce its new regulatory scheme for products that fall within the Modernization of Cosmetics Regulation Act of 2022 (MoCRA)’s purview. While MoCRA was enacted in December 2022 and many of its provisions became enforceable on December 29, 2023, until now, many have wondered how FDA will exercise its new enforcement powers....